| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEULET.2008.05.116 |
| P698 | PubMed publication ID | 18586394 |
| P50 | author | Guanhua Du | Q39032620 |
| P2093 | author name string | Xin Mu | |
| Bei Xu | |||
| Juanjuan Hu | |||
| Xiaoxiu Li | |||
| Yinxia Cheng | |||
| Tiantai Zhang | |||
| Guorong He | |||
| P2860 | cites work | The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin | Q47187156 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | toxic encephalopathy | Q7830379 |
| immunohistochemistry | Q899285 | ||
| neurotoxicity | Q3338704 | ||
| P304 | page(s) | 16-20 | |
| P577 | publication date | 2008-06-10 | |
| P1433 | published in | Neuroscience Letters | Q7002625 |
| P1476 | title | Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile | |
| P478 | volume | 441 |
| Q64786579 | Q64786579 |
| Q60046539 | A comprehensive review on phytochemistry, pharmacology, and flavonoid biosynthesis of Scutellaria baicalensis |
| Q50653719 | A novel matrix dispersion based on phospholipid complex for improving oral bioavailability of baicalein: preparation, in vitro and in vivo evaluations. |
| Q27023467 | Advances in neuroprotective ingredients of medicinal herbs by using cellular and animal models of Parkinson's disease |
| Q54397706 | Aβ-induced microglial cell activation is inhibited by baicalin through the JAK2/STAT3 signaling pathway. |
| Q34134659 | Baicalein antagonizes rotenone-induced apoptosis in dopaminergic SH-SY5Y cells related to Parkinsonism |
| Q43730264 | Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK. |
| Q44582977 | Baicalein inhibits formation of α-synuclein oligomers within living cells and prevents Aβ peptide fibrillation and oligomerisation |
| Q39052298 | Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression. |
| Q34020622 | Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism. |
| Q55395566 | Depletion of microglia augments the dopaminergic neurotoxicity of MPTP. |
| Q38784992 | Differential contribution of lipoxygenase isozymes to nigrostriatal vulnerability |
| Q37108027 | Effect of total flavonoids from Scutellaria baicalensis on dopaminergic neurons in the substantia nigra |
| Q84499270 | Efficacy of combined treatment with albendazole and baicalein against eosinophilic meningitis induced by Angiostrongylus cantonensis in mice |
| Q42713809 | Evaluation of the antioxidative properties of lipoxygenase inhibitors. |
| Q39412092 | Flavonoid baicalein modulates H2O2-induced mitogen-activated protein kinases activation and cell death in SK-N-MC cells. |
| Q52718062 | Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway. |
| Q39185205 | In silico target fishing for the potential targets and molecular mechanisms of baicalein as an antiparkinsonian agent: discovery of the protective effects on NMDA receptor-mediated neurotoxicity |
| Q37686294 | Mitochondrial metals as a potential therapeutic target in neurodegeneration |
| Q47222156 | Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson's Disease through NF-κB/pAKT Signaling Pathways. |
| Q53917426 | Multiple-Ascending-Dose Pharmacokinetics and Safety Evaluation of Baicalein Chewable Tablets in Healthy Chinese Volunteers. |
| Q47779349 | Neuroprotective Effects of Baicalein on Acrolein-induced Neurotoxicity in the Nigrostriatal Dopaminergic System of Rat Brain |
| Q86182755 | Neuroprotective role of Withania somnifera root extract in maneb-paraquat induced mouse model of parkinsonism |
| Q26752769 | Nutraceuticals in Parkinson's Disease |
| Q92183933 | Perspective: Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy |
| Q51800931 | Plant-Derived Natural Products for Parkinson's Disease Therapy. |
| Q41622472 | Plants-Derived Neuroprotective Agents: Cutting the Cycle of Cell Death through Multiple Mechanisms |
| Q36704078 | Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. |
| Q39422865 | Protective effects of baicalein against excess L-DOPA-induced dopamine quinone neurotoxicity |
| Q39438621 | Protective effects of fisetin and other berry flavonoids in Parkinson's disease |
| Q39329775 | Supplementation with Herbal Extracts to Promote Behavioral and Neuroprotective Effects in Experimental Models of Parkinson's Disease: A Systematic Review |
| Q92991007 | The Potential of Flavonoids for the Treatment of Neurodegenerative Diseases |
| Q39387480 | Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease |
| Q41565664 | Therapeutic effects of baicalein on rotenone-induced Parkinson's disease through protecting mitochondrial function and biogenesis |
Search more.